Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04590898 · ClinicalTrials.gov registry record
Peri-device Leakage Closure After LAAO
A clinical trial of Stroke and Atrial Fibrillation, sponsored by Cardiovascular Center Frankfurt.
- Completed
- Registry status
- 85
- Enrollment target
- 16
- Study locations
NCT04590898 is a study of Stroke and Atrial Fibrillation that has completed, run by Cardiovascular Center Frankfurt. The registered enrollment target is 85 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 16 study locations across 10 states.
The verdict
NCT04590898, a study of Stroke and Atrial Fibrillation, has completed, sponsored by Cardiovascular Center Frankfurt.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 16
- Study locations
Study Summary
The investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional) with different devices.
Conditions Studied
Interventions
- DEVICE Peri-device leakage closure after left atrial appendage occlusion
Study Locations (16)
Other
- Aarhus University Hospital - Aarhus
- Rigshospitalet Copenhagen - Copenhagen
- Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF) - Berlin
- Poznan University of Medical Sciences - Poznan
- Hospital Universitario de Salamanca - Salamanca
- Inselspital Bern - Bern
- Nuffield Health - Headington
Arizona
- • Banner University Medical Center Phoenix - Phoenix
California
- Scripps Health - La Jolla
Kansas
- Kansas City Heart Rhythm Institute - Overland Park
Minnesota
- Mayo Clinic Hospital - Saint Mary's Campus - Rochester
Tennessee
- Vanderbilt Heart Institute - Nashville
Texas
- Austin Heart - Austin
Utah
- University of Utah Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2020-09-27 |
| Est. Completion | 2021-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04590898
The ClinicalTrials.gov registry entry for NCT04590898 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Cardiovascular Center Frankfurt, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Peri-device leakage closure after left atrial appendage occlusion is the first listed.
NCT04590898 reports 16 study locations spanning 10 distinct geographic areas - top geographies include Other, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT04590898 about?
NCT04590898 is a clinical study titled "Peri-device Leakage Closure After LAAO". The investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional) with different devices.
What is the current status of trial NCT04590898?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2020-09-27. Estimated completion is 2021-09-01.
What conditions does trial NCT04590898 study?
This clinical trial studies the following conditions: Stroke, Atrial Fibrillation, Bleeding, Leakage of Cardiac Device.
What interventions are being tested in trial NCT04590898?
The interventions under investigation include: Peri-device leakage closure after left atrial appendage occlusion (DEVICE).
Who is sponsoring clinical trial NCT04590898?
This trial is sponsored by Cardiovascular Center Frankfurt, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04590898 being conducted?
This trial has 16 study locations across Arizona, California, Kansas, Minnesota, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.